1. Home
  2. VAC vs IMNM Comparison

VAC vs IMNM Comparison

Compare VAC & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marriott Vacations Worldwide Corporation

VAC

Marriott Vacations Worldwide Corporation

HOLD

Current Price

$67.90

Market Cap

2.3B

Sector

Finance

ML Signal

HOLD

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$23.18

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VAC
IMNM
Founded
1984
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.8B
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
VAC
IMNM
Price
$67.90
$23.18
Analyst Decision
Buy
Strong Buy
Analyst Count
9
10
Target Price
$75.13
$32.80
AVG Volume (30 Days)
452.6K
1.2M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
4.68%
N/A
EPS Growth
N/A
51.40
EPS
N/A
N/A
Revenue
$5,032,000,000.00
$6,941,000.00
Revenue This Year
$54.50
N/A
Revenue Next Year
$3.03
$1,127.34
P/E Ratio
N/A
N/A
Revenue Growth
1.31
N/A
52 Week Low
$44.58
$6.97
52 Week High
$86.33
$27.65

Technical Indicators

Market Signals
Indicator
VAC
IMNM
Relative Strength Index (RSI) 52.71 60.73
Support Level $63.47 $19.23
Resistance Level $71.87 $27.14
Average True Range (ATR) 3.07 1.16
MACD -0.24 0.28
Stochastic Oscillator 53.94 90.71

Price Performance

Historical Comparison
VAC
IMNM

About VAC Marriott Vacations Worldwide Corporation

Marriott Vacations Worldwide Corp functions in the United States leisure industry. It owns and manages a cluster of resorts and accommodation facilities under trademarks like Marriott Vacation Club, Grand Residencies, and The Ritz-Carlton Destination Club predominantly in the United States. Some of its properties are also spread across Europe and Asia Pacific. Marriott's majority revenue components include the sale of vacation ownership products such as luxurious vacation packages. In addition, it offers purchase money financing to the end users of its core services. The company operates in two reportable segments: Vacation Ownership and Exchange & Third-Party Management. The majority of revenue is derived from the Vacation Ownership segment.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: